Jane Sayi

1.0k total citations
16 papers, 752 citations indexed

About

Jane Sayi is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Jane Sayi has authored 16 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Jane Sayi's work include Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (6 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Jane Sayi is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (6 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Jane Sayi collaborates with scholars based in Tanzania, Sweden and Zimbabwe. Jane Sayi's co-authors include Lars L. Gustafsson, Leif Bertilsson, Julia A. Hasler, Collet Dandara, Eleni Aklillu, Magnus Ingelman‐Sundberg, Mary Jande, Collen Masimirembwa, J. R. Snyman and Sylvia Kaaya and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Clinical Pharmacology & Therapeutics and Brain Pathology.

In The Last Decade

Jane Sayi

16 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Sayi Tanzania 15 437 231 130 111 90 16 752
Alison E. Aitken United States 6 352 0.8× 234 1.0× 160 1.2× 74 0.7× 59 0.7× 6 767
Amarjit S. Chaudhry United States 17 308 0.7× 207 0.9× 182 1.4× 141 1.3× 82 0.9× 20 737
Yacoub M. Irshaid Jordan 13 263 0.6× 139 0.6× 163 1.3× 86 0.8× 59 0.7× 48 697
B K Park United Kingdom 14 423 1.0× 186 0.8× 299 2.3× 176 1.6× 66 0.7× 26 1.1k
Kari T Kivist Germany 8 410 0.9× 287 1.2× 139 1.1× 151 1.4× 81 0.9× 8 861
Manoranjenni Chetty United Kingdom 18 217 0.5× 205 0.9× 221 1.7× 179 1.6× 49 0.5× 41 953
Darryl Gilbert United States 8 359 0.8× 239 1.0× 118 0.9× 88 0.8× 71 0.8× 8 626
Marina Kacevska Australia 14 373 0.9× 384 1.7× 364 2.8× 160 1.4× 97 1.1× 14 1.2k
Alison E. Fohner United States 18 322 0.7× 148 0.6× 140 1.1× 122 1.1× 55 0.6× 47 962
Rasmus S. Pedersen Denmark 19 515 1.2× 317 1.4× 168 1.3× 173 1.6× 135 1.5× 35 1.1k

Countries citing papers authored by Jane Sayi

Since Specialization
Citations

This map shows the geographic impact of Jane Sayi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Sayi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Sayi more than expected).

Fields of papers citing papers by Jane Sayi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Sayi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Sayi. The network helps show where Jane Sayi may publish in the future.

Co-authorship network of co-authors of Jane Sayi

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Sayi. A scholar is included among the top collaborators of Jane Sayi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Sayi. Jane Sayi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Diczfalusy, Ulf, Jun Miura, Hyung‐Keun Roh, et al.. (2008). 4β-Hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians. Pharmacogenetics and Genomics. 18(3). 201–208. 128 indexed citations
2.
Ngassapa, Olipa, et al.. (2007). Quality of antiretroviral drugs, stavudine and indinavir capsules available in the Tanzanian market. 21(1). 8–12. 1 indexed citations
3.
Josephson, Filip, Mohamed Janabi, Jane Sayi, et al.. (2007). CYP3A5 Genotype has an Impact on the Metabolism of the HIV Protease Inhibitor Saquinavir. Clinical Pharmacology & Therapeutics. 81(5). 708–712. 48 indexed citations
4.
Mirghani, Rajaa A., Jane Sayi, Eleni Aklillu, et al.. (2006). CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population. Pharmacogenetics and Genomics. 16(9). 637–645. 63 indexed citations
5.
Bapiro, Tashinga E., et al.. (2005). Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans. European Journal of Clinical Pharmacology. 61(10). 755–761. 32 indexed citations
6.
Rodríguez‐Antona, Cristina, Jane Sayi, Lars L. Gustafsson, Leif Bertilsson, & Magnus Ingelman‐Sundberg. (2005). Phenotype–genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles. Biochemical and Biophysical Research Communications. 338(1). 299–305. 88 indexed citations
7.
Dandara, Collet, et al.. (2004). Frequency of –163 C > A and 63 C > G single nucleotide polymorphism of cytochrome P450 1A2 in two African populations. Clinical Chemistry and Laboratory Medicine (CCLM). 42(8). 939–41. 15 indexed citations
8.
Dandara, Collet, Collen Masimirembwa, Ayoub Magimba, et al.. (2003). Arylamine N-acetyltransferase (NAT2) genotypes in Africans. Pharmacogenetics. 13(1). 55–58. 35 indexed citations
9.
Dandara, Collet, Jane Sayi, Collen Masimirembwa, et al.. (2002). Genetic Polymorphism of Cytochrome P450 1A1 (CYP1A1) and Glutathione Transferases (M1, T1 and P1) among Africans. Clinical Chemistry and Laboratory Medicine (CCLM). 40(9). 952–7. 47 indexed citations
10.
Yaşar, Ümit, Eleni Aklillu, Roberto Canaparo, et al.. (2002). Analysis of CYP2C9*5 in Caucasian, Oriental and Black-African populations. European Journal of Clinical Pharmacology. 58(8). 555–558. 44 indexed citations
11.
Dandara, Collet, Collen Masimirembwa, Ayoub Magimba, et al.. (2001). Genetic polymorphism of CYP2D6 and CYP2C19 in East- and Southern African populations including psychiatric patients. European Journal of Clinical Pharmacology. 57(1). 11–17. 74 indexed citations
12.
Wennerholm, Agneta, Collet Dandara, Jane Sayi, et al.. (2001). The African‐specific CYP2D6*17 allele encodes an enzyme with changed substrate specificity. Clinical Pharmacology & Therapeutics. 71(1). 77–88. 69 indexed citations
13.
Kalaria, Raj N., Julius A Ogeng’o, Nilesh B. Patel, et al.. (1997). Evaluation of Risk Factors for Alzheimer’s Disease in Elderly East Africans. Brain Research Bulletin. 44(5). 573–577. 32 indexed citations
14.
Sayi, Jane, Nilesh B. Patel, Daniel R. Premkumar, et al.. (1997). Apolipoprotein E polymorphism in elderly east Africans.. PubMed. 74(10). 668–70. 31 indexed citations
15.
Ogeng’o, Julius A, David Cohen, Jane Sayi, et al.. (1996). Cerebral Amyloid β Protein Deposits and Other Alzheimer Lesions in Non‐Demented Elderly East Africans. Brain Pathology. 6(2). 101–107. 21 indexed citations
16.
Massele, Amos, Jane Sayi, Stephen E. D. Nsimba, David Ofori‐Adjei, & Richard Laing. (1993). Knowledge and management of malaria in Dar es Salaam, Tanzania.. PubMed. 70(10). 639–42. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026